| Literature DB >> 25559470 |
Yoon Hong Chun1, Kyungdo Han2, Shin Hae Park3, Kyung-Min Park4, Hyeon Woo Yim5, Won-Chul Lee5, Yong Gyu Park2, Yong-Moon Park6.
Abstract
Based on reports of an association between elevated intraocular pressure (IOP) and metabolic syndrome (MetS), and the major role of insulin resistance (IR) in MetS pathogenesis, a positive association between IOP and IR has been hypothesized. Although Asian populations tend to have lower body mass indices (BMIs) than Western populations, they tend to have a higher risk of developing MetS. This study examined the hypothesis that the association between IOP and IR differs by obesity status in an Asian population, by examining a nationally representative sample of South Korean adults. Data collected from 4,621 South Korean adults regarding demographic, lifestyle, and laboratory parameters by the 2010 Korea National Health and Nutrition Examination Survey were subjected to linear regression analysis to evaluate the relationship between IOP and metabolic profiles. After adjusting for confounding factors, the data were subjected to multiple linear regression analysis to examine the association between IR, as measured by the homeostasis model assessment of insulin resistance (HOMA-IR), and IOP. Obesity was defined as BMI≥27.5 kg/m2, and the subjects were divided into obese vs. non-obese groups for investigation of the association between IR and IOP according to obesity status. IOP was found to correlate with fasting blood sugar, total cholesterol, insulin, and HOMA-IR values in non-obese men; and with BMI, waist circumference, triglycerides, total cholesterol, HOMA-IR, and low-density lipoprotein cholesterol values in non-obese women, whereas no association between IOP and IR was found in obese men or women. IOP was significantly associated with IR in non-obese men and women after adjusting for age, and in non-obese men after adjusting for age, BMI, and lifestyle and demographic factors. These findings indicate that a positive and independent relationship exists between IOP and IR in non-obese individuals only, suggesting that other factors likely contribute to IOP elevation in obese individuals.Entities:
Mesh:
Year: 2015 PMID: 25559470 PMCID: PMC4283958 DOI: 10.1371/journal.pone.0112929
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
General characteristics of the study subjects.
| Male | Female | |||||
| Non-obese | Obese | P-value | Non-obese | Obese | P-value | |
| (n = 1272) | (n = 719) | (n = 1949) | (n = 681) | |||
|
| 42.2±0.6 | 42.1±0.7 | <.0001 | 42.1±0.5 | 48.5±0.7 | <.0001 |
|
| 22.1±0.1 | 27.4±0.1 | <.0001 | 21.5±0.1 | 27.7±0.1 | <.0001 |
|
| 79.2±0.2 | 91.8±0.4 | <.0001 | 73.3±0.3 | 87.8±0.4 | <.0001 |
|
| 14.1±0.1 | 14.5±0.2 | <.0001 | 13.7±0.1 | 14.1±0.2 | <.0001 |
|
| 91.7±0.4 | 96±0.4 | <.0001 | 89.5±0.2 | 94.7±0.5 | <.0001 |
|
| 108.2 (103.6,113) | 156.2 (147.9,164.9) | <.0001 | 81.3 (79.1, 83.7) | 115.2 (109.4, 121.2) | <.0001 |
|
| 182.2±1.2 | 197.2±1.6 | <.0001 | 181.5±1 | 198.1±1.8 | <.0001 |
|
| 8.6 (8.4,8.8) | 11.5 (11.1, 11.9) | <.0001 | 9 (8.8, 9.2) | 11.4 (11, 11.8) | <.0001 |
|
| 1.9 (1.9,2) | 2.7 (2.6, 2.8) | <.0001 | 2 (1.9, 2) | 2.6 (2.5, 2.8) | <.0001 |
|
| 51.8±0.5 | 46.9±0.5 | <.0001 | 57.8±0.4 | 51.9±0.5 | <.0001 |
|
| 109.1±1.1 | 119.4±1.6 | <.0001 | 110.2±0.8 | 124.3±1.5 | <.0001 |
|
| 44 (1.5) | 41.4 (2.4) | 0.3393 | 5 (0.6) | 6.1 (1.4) | 0.4334 |
|
| 16.2 (1.1) | 20.8 (1.8) | 0.0262 | 1.6 (0.4) | 3.3 (0.9) | 0.0320 |
|
| 25.4 (1.5) | 25.5 (2.1) | 0.9735 | 18.6 (1.2) | 26 (2.1) | 0.0002 |
|
| 22.1 (3.5) | 19.6 (3.3) | 0.3238 | 19.5 (3) | 26 (4) | 0.0047 |
|
| 21.3 (1.6) | 16 (1.6) | 0.0100 | 26.3 (1.7) | 47.6 (2.5) | <.0001 |
|
| 13.3 (1.4) | 11 (1.4) | 0.1906 | 14.9 (1.1) | 22.9 (2.3) | 0.0002 |
|
| 80.1 (1.5) | 84.5 (2) | 0.0824 | 54.9 (1.6) | 53.9 (2.2) | 0.7173 |
|
| 2.5 (0.5) | 2.1 (0.7) | 0.6504 | 2.5 (0.4) | 1.4 (0.5) | 0.1624 |
|
| 0.6761 | 0.8443 | ||||
|
| 55.3 (2.1) | 54.4 (2.2) | 70.9 (1.5) | 69.6 (2.5) | ||
|
| 28.5 (1.7) | 27.6 (2) | 20.5 (1.2) | 21.2 (2) | ||
|
| 16.1 (1.6) | 18 (1.8) | 8.6 (1.2) | 9.2 (1.5) | ||
|
| 26.5 (1.5) | 42.5 (2.7) | <.0001 | |||
Data are presented as mean ± standard deviation or n (%).
Abbreviations: BMI = Body Mass Index, WC = Waist circumference, IOP = Intraocular pressure, FBS = Fasting Blood Sugar, TG = Triglycerides, TC = Total Cholesterol, HOMA-IR = Homeostasis Model Assessment of Insulin Resistance, HDL = High Density Lipoprotein Cholesterol, LDL = Low Density Lipoprotein Cholesterol, FHx = Family History.
Association between IOP and metabolic profile components by sex and obesity status.
| Male | Female | |||||||
| Non obese | Obese | Non obese | Obese | |||||
| r | P-value | r | P-value | r | P-value | r | P-value | |
|
| 0.05117 | 0.1320 | −0.04081 | 0.3726 | 0.05294 | 0.0615 | −0.10913 | 0.0376 |
|
| 0.04562 | 0.1563 | 0.05849 | 0.2437 | 0.07316 | 0.0170 | 0.03797 | 0.4403 |
|
| −0.01450 | 0.4253 | 0.03598 | 0.4492 | 0.11830 | 0.0010 | −0.00446 | 0.9199 |
|
| 0.09819 | 0.0135 | 0.06424 | 0.1214 | 0.04040 | 0.1235 | 0.00631 | 0.9082 |
|
| 0.06285 | 0.0803 | 0.05340 | 0.2719 | 0.05073 | 0.0426 | 0.01565 | 0.7074 |
|
| 0.08879 | 0.0042 | 0.07498 | 0.0643 | 0.08702 | 0.0022 | −0.03566 | 0.5219 |
|
| 0.07505 | 0.0305 | 0.00764 | 0.8531 | 0.05298 | 0.0645 | −0.02564 | 0.6052 |
|
| 0.09122 | 0.0078 | 0.02143 | 0.6026 | 0.05783 | 0.0344 | −0.02318 | 0.6494 |
|
| 0.01837 | 0.5528 | 0.05214 | 0.2461 | 0.01490 | 0.6116 | −0.0258 | 0.5371 |
|
| 0.05769 | 0.0807 | 0.02490 | 0.5339 | 0.07761 | 0.0065 | −0.03447 | 0.5210 |
* Regression coefficient.
p, value calculated by simple linear regression analysis.
Abbreviations: BMI = Body Mass Index, WC = Waist circumference, IOP = Intraocular pressure, FBS = Fasting Blood Sugar, TG = Triglycerides, TC = Total Cholesterol, HOMA-IR = Homeostasis Model Assessment of Insulin Resistance, HDL = High Density Lipoprotein Cholesterol, LDL = Low Density Lipoprotein Cholesterol.
Multiple linear regression analysis of the associations between mean intraocular pressure and insulin resistance by sex and obesity status.
| Non obese | Obese | ||||||
| Beta | SE | P-value | Beta | SE | P-value | ||
|
| |||||||
| MODEL1 | 0.680466 | 0.252759 | 0.0078 | 0.142091 | 0.272408 | 0.6026 | |
| MODEL2 | 0.659045 | 0.260247 | 0.0123 | −0.028270 | 0.312774 | 0.9281 | |
|
| 0.527542 | 0.265365 | 0.0484 | 0.343015 | 0.344363 | 0.3206 | |
|
| |||||||
| MODEL1 | 0.424281 | 0.198966 | 0.0344 | −0.141510 | 0.310742 | 0.6494 | |
| MODEL2 | 0.339676 | 0.200434 | 0.0920 | −0.206070 | 0.327547 | 0.5301 | |
| MODEL4 | 0.435297 | 0.215540 | 0.0450 | −0.144795 | 0.406476 | 0.7221 | |
* Standardized coefficient.
Model 1: adjusted for age.
Model 2: adjusted for age, body mass index, smoking status, alcohol consumption, exercise level, educational level, and family income.
3: adjusted for age, body mass index, smoking status, alcohol consumption, exercise level, educational level, family income, family history of glaucoma, and sun exposure, daily calorie intake, and daily fat intake.
Model 4: adjusted for age, body mass index, smoking status, alcohol consumption, exercise level, educational level, family income, family history of glaucoma, sun exposure, daily calorie intake, daily fat intake, menopause, and hormonal replacement therapy.
Abbreviations: SE = standard error.
Figure 1Changes in intraocular pressure according to insulin resistance quartiles in non-obese and obese men and women.
The linear graph shows a gradual increase in the mean intraocular pressure with the higher quartile of insulin resistance in non-obese men and women (p for trend = 0.0006 for men; 0.0096 for women), but not in obese men and women (p for trend = 0.8121 for men; 0.3596 for women).